122 related articles for article (PubMed ID: 1905748)
1. Sensitive competitive-binding ELISAs for quantifying free kappa and lambda light chains in cerebrospinal fluid.
Stanescu GL; Swick AR; Tuohy VK; Rudick RA
J Clin Lab Anal; 1991; 5(3):206-11. PubMed ID: 1905748
[TBL] [Abstract][Full Text] [Related]
2. [Immunoenzymatic determination of free immunoglobulin light chains in the cerebrospinal fluid: its value in the biological diagnosis of multiple sclerosis].
Allal C; Ghaffor M; Rabhi H; Chaouche M; Tazir M; Abbadi MC
Arch Inst Pasteur Alger; 1989; 57():111-24. PubMed ID: 2518740
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.
Zeman D; Kušnierová P; Švagera Z; Všianský F; Byrtusová M; Hradílek P; Kurková B; Zapletalová O; Bartoš V
PLoS One; 2016; 11(11):e0166556. PubMed ID: 27846293
[TBL] [Abstract][Full Text] [Related]
5. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid.
Arneth B; Birklein F
Acta Neurol Scand; 2009 Jan; 119(1):39-44. PubMed ID: 18573131
[TBL] [Abstract][Full Text] [Related]
6. Free kappa light chains in multiple sclerosis spinal fluid.
Rudick RA; Pallant A; Bidlack JM; Herndon RM
Ann Neurol; 1986 Jul; 20(1):63-9. PubMed ID: 3090930
[TBL] [Abstract][Full Text] [Related]
7. Oligoclonal free kappa and lambda bands in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. An immunoaffinity-mediated capillary blot study.
Sindic CJ; Laterre EC
J Neuroimmunol; 1991 Jul; 33(1):63-72. PubMed ID: 1829093
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis: use of light-chain typing to assist diagnosis.
Jenkins MA; Cheng L; Ratnaike S
Ann Clin Biochem; 2001 May; 38(Pt 3):235-41. PubMed ID: 11392498
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis: assay of free immunoglobulin light chains.
Ramsden DB
Ann Clin Biochem; 2017 Jan; 54(1):5-13. PubMed ID: 27170023
[TBL] [Abstract][Full Text] [Related]
10. Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
Fagnart OC; Sindic CJ; Laterre C
J Neuroimmunol; 1988 Aug; 19(1-2):119-32. PubMed ID: 3135296
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
Makshakov G; Nazarov V; Kochetova O; Surkova E; Lapin S; Evdoshenko E
PLoS One; 2015; 10(11):e0143375. PubMed ID: 26606531
[TBL] [Abstract][Full Text] [Related]
12. Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.
Huss A; Mojib-Yezdani F; Bachhuber F; Fangerau T; Lewerenz J; Otto M; Tumani H; Senel M
Clin Chim Acta; 2019 Nov; 498():148-153. PubMed ID: 31437445
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of IgG kappa and IgG lambda in the cerebrospinal fluid by sandwich ELISA method.
Zeman D; Kušnierová P; Bojková J; Všianský F; Zapletalová O
J Immunoassay Immunochem; 2017; 38(2):165-177. PubMed ID: 27611231
[TBL] [Abstract][Full Text] [Related]
15. Identification of the kappa and lambda light chains within the CSF immunoglobulin region in multiple sclerosis and subacute sclerosing panencephalitis by immunofixation after isoelectric focusing.
Rocchelli B; Poloni M; Mazzarello P; Delodovici M
J Neurol; 1981; 226(3):169-79. PubMed ID: 6172564
[TBL] [Abstract][Full Text] [Related]
16. Kappa/lambda ratios in IgG, IgA and IgM of cerebrospinal fluid and of sera in patients with multiple sclerosis.
Araga S; Kagimoto H; Wada A; Funamoto K; Inoue K; Takahashi K
Autoimmunity; 1989; 5(1-2):133-7. PubMed ID: 2519013
[TBL] [Abstract][Full Text] [Related]
17. Determination of k/l immunoglobulin light chain ratios in CSF from patients with multiple sclerosis and other neurological diseases.
Eickhoff K; Heipertz R; Wikström J
Acta Neurol Scand; 1978 May; 57(5):385-95. PubMed ID: 97915
[TBL] [Abstract][Full Text] [Related]
18. Measurement of free kappa immunoglobulin light chains in the cerebrospinal fluid by a competitive avidin-biotin ELISA.
Lolli F; Amaducci L
Clin Chim Acta; 1989 Jun; 182(2):229-34. PubMed ID: 2505952
[No Abstract] [Full Text] [Related]
19. Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation.
Vakaet A; Thompson EJ
J Neurol Neurosurg Psychiatry; 1985 Oct; 48(10):995-8. PubMed ID: 3932600
[TBL] [Abstract][Full Text] [Related]
20. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
Kaplan B; Golderman S; Yahalom G; Yeskaraev R; Ziv T; Aizenbud BM; Sela BA; Livneh A
J Immunol Methods; 2013 Apr; 390(1-2):74-80. PubMed ID: 23376556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
